# SOLV catalysts: Solventum Corp PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/solv/catalysts

> Solventum Corp (SOLV) has no upcoming catalysts in this calendar. The latest recorded is the Soluprep S (chlorhexidine gluconate; isopropyl alcohol) label expansion decision, January 20, 2023.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Company

| Field | Value |
| --- | --- |
| Name | Solventum Corp |
| Ticker | SOLV (NYSE) |
| SEC CIK | 1964738 |
| SIC | 3841 |
| SEC filings | https://sec-api.dev/companies/solv |

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| August 8, 2018 | [Soluprep S (chlorhexidine gluconate; isopropyl alcohol) FDA approval](https://sec-api.dev/pdufa/chlorhexidine-gluconate-isopropyl-alcohol) | SOLV |  | completed, approved | "NDA208288 ORIG-1 (Type 5 - New Formulation or New Manufacturer): submission_status AP, submission_status_date 20180808, review_priority STANDARD; sponsor_name SOLVENTUM; product SOLUPREP S (CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL)." ([openFDA Drugs@FDA](https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208288%22)) |
| January 20, 2023 | [Soluprep S (chlorhexidine gluconate; isopropyl alcohol) label expansion decision](https://sec-api.dev/pdufa/chlorhexidine-gluconate-isopropyl-alcohol) | SOLV |  | completed, approved | "NDA208288 SUPPL-4 (Efficacy): submission_status AP, submission_status_date 20230120, review_priority STANDARD; sponsor_name SOLVENTUM; product SOLUPREP S (CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL)." ([openFDA Drugs@FDA](https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208288%22)) |

## Drugs

- [Soluprep S (chlorhexidine gluconate; isopropyl alcohol)](https://sec-api.dev/pdufa/chlorhexidine-gluconate-isopropyl-alcohol): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/solv/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "SOLV catalysts: Solventum Corp PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/solv/catalysts

```bibtex
@misc{secapidev_companies_solv_catalysts_20261116,
  title        = {SOLV catalysts: Solventum Corp PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/solv/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_solv_catalysts_20261116","title":"SOLV catalysts: Solventum Corp PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/solv/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
